Evidence map›Paper›PMID 38712029›Full record

ArticlebioRxiv : the preprint server for biology2024

PROSTATE CELL HETEROGENEITY AND CXCL17 UPREGULATION IN MOUSE STEROID HORMONE IMBALANCE.

Samara V Silver, Kayah J Tucker, Renee E Vickman, Nadia A Lanman, O John Semmes, Nehemiah S Alvarez, Petra Popovics

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Samara V SilverDepartment of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, VA.
Kayah J TuckerDepartment of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, VA.
Renee E VickmanDepartment of Surgery, Endeavor Health, an Academic Affiliate of the University of Chicago Pritzker School of Medicine, Evanston, IL, USA.
Nadia A LanmanInstitute for Cancer Research, Purdue University, West Lafayette, IN, USA.
O John SemmesDepartment of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, VA.
Nehemiah S AlvarezDepartment of Surgery, Endeavor Health, an Academic Affiliate of the University of Chicago Pritzker School of Medicine, Evanston, IL, USA.
Petra PopovicsDepartment of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, VA.

Funding

Virginia-UCLA-Toronto Biomarker Characterization CenterU2CCA271894 · NCI · OLD DOMINION UNIVERSITY · PI OLIVER John SEMMES · 2022 to 2026
$3.2M
Osteopontin: A Novel Mediator of prostatic inflammation and fibrosisK01DK127150 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI POPOVICS, PETRA · 2021 to 2025
$630k
NCI NIH HHS U2C CA271894NIDDK NIH HHS K01 DK127150
6 · The paper itself

Abstract

Benign prostatic hyperplasia (BPH) is a prevalent age-related condition often characterized by debilitating urinary symptoms. Its etiology is believed to stem from hormonal imbalance, particularly an elevated estradiol-to-testosterone ratio and chronic inflammation. Our previous studies using a mouse steroid hormone imbalance model identified a specific increase in macrophages that migrate and accumulate in the prostate lumen where they differentiate into lipid-laden foam cells in mice implanted with testosterone and estradiol pellets, but not in sham animals. The current study focused on further characterizing the cellular heterogeneity of the prostate in this model as well as identifying the specific transcriptomic signature of the recruited foam cells. Moreover, we aimed to identify the epithelia-derived signals that drive macrophage infiltration and luminal translocation. Male C57BL/6J mice were implanted with slow-release testosterone and estradiol pellets (T+E2) and harvested the ventral prostates two weeks later for scRNA-seq analysis, or performed sham surgery. We identified

Indexed as

benign prostatic hyperplasiacytokinesfoam cellslower urinary tract symptoms

Identifiers

PMID38712029
PMCPMC11071464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.